What one share of Palvella Therapeutics holds
On December 13, 2024, we completed the previously announced business combination with Legacy Palvella in accordance with the terms of the Merger Agreement, pursuant to which, among other matters, Merger Sub merged with and into Legacy Palvella, with Legacy Palvella surviving as our wholly owned subsidiary (such business combination, the Merger).
Palvella Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$4.90 |
|---|---|
| Cash and investments | $13.05 |
| Book value | $15.06 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | $30.94 | −$56.80 | $1.54 | −$30.76 | — | — |
| 2015 | $6.82 | −$32.70 | $1.44 | −$31.00 | — | $62.52 |
| 2016 | $11.18 | −$43.73 | $1.07 | −$28.67 | — | $46.87 |
| 2017 | $46.03 | −$32.14 | $3.55 | $87.05 | — | $20.48 |
| 2018 | $43.86 | −$40.32 | $2.56 | −$4.17 | — | $59.00 |
| 2019 | $73.13 | −$44.72 | $3.89 | −$86.80 | — | $74.41 |
| 2020 | $43.06 | −$54.67 | $4.00 | −$71.40 | — | $44.32 |
| 2021 | $38.94 | −$56.69 | $1.18 | −$10.67 | — | $56.22 |
| 2022 | $27.94 | −$35.89 | $1.12 | −$65.76 | — | −$100.67 |
| 2023 | $23.86 | $2.17 | $0.10 | −$7.73 | — | −$42.08 |
| 2024 | — | −$7.83 | — | — | — | — |
| 2025 | — | −$3.71 | — | — | — | $2.26 |
Common questions about Palvella Therapeutics
How much does one share of Palvella Therapeutics earn?
Over the last 12 months, Palvella Therapeutics lost $4.90 for each share.
Does Palvella Therapeutics pay a dividend?
Palvella Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Palvella Therapeutics’s book value per share?
Palvella Therapeutics’s book value is $15.06 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Palvella Therapeutics have?
Each share of Palvella Therapeutics has $13.05 of cash and investments, as of June 30, 2026.
Has Palvella Therapeutics bought back shares?
Palvella Therapeutics’s share count rose about 6388% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.